-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 19,, Shandong Lu Anti-Pharmaceutical Co., Ltdreleased its 2013 annual report, saying that its 2013 operating income was RMB2,211 million, down 5.5% YoY;6Gy
Facing the complex and changing market environment in 2013, the company to ensure the realization of the full-year turnaround target, market demand-oriented, optimize product structure, expand the production and sales of profitable products, appropriately reduce the production of loss-making products6Gy
Among them, wholly-owned subsidiary Shandong Lu Anti-Bio Manufacturing Co., Ltd., main lyptopine manufacturing, sales; During the reporting period, operating income was RMB123.24 million and net profit was RMB64.52 million6GyOn April 19, Shandong Lu Anti-Pharmaceutical Co., Ltdreleased its 2013 annual report, which reported 2.211 billion yuan in 2013, down 5.5% YoY;6Gy
Facing the complex and changing market environment in 2013, the company to ensure the realization of the full-year turnaround target, market demand-oriented, optimize product structure, expand the production and sales of profitable products, appropriately reduce the production of loss-making products6Gy
Among them, wholly-owned subsidiary Shandong Lu Anti-Bio Manufacturing Co., Ltd., main lyptopine manufacturing, sales; During the reporting period, operating income was RMB123.24 million and net profit was RMB64.52 million 6Gy
Share it on feed